These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8531077)

  • 21. Cardiovascular effects of CPU-23, a novel L-type calcium channel blocker with a unique molecular structure.
    Dong H; Earle ML; Jiang Y; Loutzenhiser KA; Triggle CR
    Br J Pharmacol; 1997 Dec; 122(7):1271-8. PubMed ID: 9421272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
    Zakhari S
    Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of some calcium-channel blockers on human peripheral arteries and veins.
    Sjöberg T; Andersson KE; Norgren L; Steen S
    Acta Physiol Scand; 1987 Jul; 130(3):419-27. PubMed ID: 2820194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effects of calcium antagonists PN 200-110, nifedipine, and nimodipine on human and canine cerebral arteries.
    Müller-Schweinitzer E; Neumann P
    J Cereb Blood Flow Metab; 1983 Sep; 3(3):354-61. PubMed ID: 6223932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydropyridines inhibit acetylcholine-induced hyperpolarization in cochlear artery via blockade of intermediate-conductance calcium-activated potassium channels.
    Jiang ZG; Shi XR; Guan BC; Zhao H; Yang YQ
    J Pharmacol Exp Ther; 2007 Feb; 320(2):544-51. PubMed ID: 17082310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of long-term, high-altitude hypoxia on tension and intracellular calcium responses in coronary arteries of fetal and adult sheep.
    Kono S; Stiffel VM; Gilbert RD
    J Soc Gynecol Investig; 2006 Jan; 13(1):11-8. PubMed ID: 16303320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium.
    Boyd RA; Giacomini JC; Wong FM; Nelson WL; Giacomini KM
    J Pharmacol Exp Ther; 1987 Oct; 243(1):118-25. PubMed ID: 2822893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasodilator action of calcium antagonists in coronary arteries in vitro.
    Kalsner S
    J Pharmacol Exp Ther; 1997 May; 281(2):634-42. PubMed ID: 9152367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of calcium entry blockers on KCl- and 5-hydroxytryptamine-induced contractions of human umbilical arteries.
    Salom JB; Campos V; Perales A; Torregrosa G; Miranda FJ; Alabadi JA; Alborch E
    Arch Int Pharmacodyn Ther; 1990; 304():219-31. PubMed ID: 2241413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of induction of capacitative calcium entry on equine laminar microvessels.
    Robertson TP; Peroni JF; Lewis SJ; Moore JN
    Am J Vet Res; 2005 Nov; 66(11):1877-80. PubMed ID: 16334943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues.
    Angelico P; Guarneri L; Leonardi A; Testa R
    J Pharm Pharmacol; 1999 Jun; 51(6):709-14. PubMed ID: 10454048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists.
    Apostolakos MJ; Varon ME
    New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies.
    Godfraind T; Salomone S; Dessy C; Verhelst B; Dion R; Schoevaerts JC
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S34-41. PubMed ID: 1282611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative cardiovascular actions of clentiazem, diltiazem, verapamil, nifedipine, and nimodipine in isolated rabbit tissues.
    Mecca TE; Love SD
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):678-82. PubMed ID: 1280727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasodilatory properties in vascular smooth muscle of the calcium antagonist NB-818 compared to nicardipine and nimodipine.
    Nishikibe M; Fukuroda T; Nakajima A
    Arch Int Pharmacodyn Ther; 1989; 297():98-111. PubMed ID: 2730244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
    Ezra D; Boyd LM; Goldstein RE; Feuerstein G
    J Pharmacol Exp Ther; 1985 Apr; 233(1):229-34. PubMed ID: 3981457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of calcium entry blockers on calcium-dependent contractions of rat portal vein.
    Dacquet C; Mironneau C; Mironneau J
    Br J Pharmacol; 1987 Sep; 92(1):203-11. PubMed ID: 2959345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
    Nakaya H; Hattori Y; Nakao Y; Kanno M
    Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent vasoconstrictor actions of cyclopiazonic acid and thapsigargin on femoral arteries from spontaneously hypertensive rats.
    Nomura Y; Asano M; Ito K; Uyama Y; Imaizumi Y; Watanabe M
    Br J Pharmacol; 1997 Jan; 120(1):65-73. PubMed ID: 9117100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular selectivity of seven prototype calcium antagonists: a study at the single cell level.
    Pérez-Vizcaíno F; Tamargo J; Hof RP; Rüegg UT
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):768-75. PubMed ID: 7506331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.